Jason T. Duskey

Modena, 41125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Nanotechnological and in vivo characterization of a new generation of brain-permeable nanoparticles for brain-targeted cholesterol delivery in Huntington's disease.

Nanotechnological and in vivo characterization of a new generation of brain-permeable nanoparticles for brain-targeted cholesterol delivery in Huntington's disease.

Journal: International journal of pharmaceutics

Published: July 07, 2026

Drug delivery systems for mitochondrial targeting.

Drug delivery systems for mitochondrial targeting.

Journal: Nanoscale

Published: November 24, 2025

Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598.

Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 31, 2025

Corrigendum to "Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease" [Pharmacol. Res. 194 (2023) 106823].

Corrigendum to "Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease" [Pharmacol. Res. 194 (2023) 106823].

Journal: Pharmacological research

Published: October 22, 2025

Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs.

Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs.

Journal: Nanomedicine (London, England)

Published: January 24, 2025

Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.

Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.

Journal: International journal of nanomedicine

Published: February 12, 2024

Challenges of enzyme therapy: Why two players are better than one.

Challenges of enzyme therapy: Why two players are better than one.

Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Published: January 02, 2024

Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.

Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.

Journal: International journal of pharmaceutics

Published: December 01, 2023

Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor.

Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor.

Journal: Advances in neurobiology

Published: July 22, 2023

Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136].

Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136].

Journal: International journal of pharmaceutics: X

Published: July 03, 2023

"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury.

"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury.

Journal: Cells

Published: April 12, 2023

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease.

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease.

Journal: Pharmacological research

Published: April 12, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026